
| MICRON TECHNOLOGY, INC. | ||
| (Exact name of registrant as specified in its charter) | ||
| Delaware | 1-10658 | 75-1618004 | ||||||||||||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| 8000 South Federal Way | ||
Boise, Idaho 83716-9632 | ||
| (Address of principal executive offices and Zip Code) | ||
(208) 368-4000 | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Common Stock, par value $0.10 per share | MU | Nasdaq Global Select Market | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | December 17, 2025 | By: | /s/ Mark Murphy | ||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Satya Kumar | Mark Plungy | ||||||
| Investor Relations | Media Relations | |||||||
satyakumar@micron.com | mplungy@micron.com | |||||||
(408) 450-6199 | (408) 203-2910 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
| FQ1-26 | FQ4-25 | FQ1-25 | FQ1-26 | FQ4-25 | FQ1-25 | ||||||||||||||||||
| Revenue | $ | 13,643 | $ | 11,315 | $ | 8,709 | $ | 13,643 | $ | 11,315 | $ | 8,709 | |||||||||||
| Gross margin | 7,646 | 5,054 | 3,348 | 7,753 | 5,169 | 3,441 | |||||||||||||||||
| Percent of revenue | 56.0 | % | 44.7 | % | 38.4 | % | 56.8 | % | 45.7 | % | 39.5 | % | |||||||||||
| Operating expenses | 1,510 | 1,400 | 1,174 | 1,334 | 1,214 | 1,047 | |||||||||||||||||
| Operating income | 6,136 | 3,654 | 2,174 | 6,419 | 3,955 | 2,394 | |||||||||||||||||
| Percent of revenue | 45.0 | % | 32.3 | % | 25.0 | % | 47.0 | % | 35.0 | % | 27.5 | % | |||||||||||
| Net income | 5,240 | 3,201 | 1,870 | 5,482 | 3,469 | 2,037 | |||||||||||||||||
| Diluted earnings per share | 4.60 | 2.83 | 1.67 | 4.78 | 3.03 | 1.79 | |||||||||||||||||
| FQ2-26 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $18.70 billion ± $400 million | $18.70 billion ± $400 million | ||||||
Gross margin | 67.0% ± 1.0% | 68.0% ± 1.0% | ||||||
Operating expenses | $1.56 billion ± $20 million | $1.38 billion ± $20 million | ||||||
Diluted earnings per share | $8.19 ± $0.20 | $8.42 ± $0.20 | ||||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 27, 2025 | August 28, 2025 | November 28, 2024 | |||||||||
| Revenue | $ | 13,643 | $ | 11,315 | $ | 8,709 | |||||
| Cost of goods sold | 5,997 | 6,261 | 5,361 | ||||||||
| Gross margin | 7,646 | 5,054 | 3,348 | ||||||||
| Research and development | 1,171 | 1,047 | 888 | ||||||||
| Selling, general, and administrative | 337 | 314 | 288 | ||||||||
| Other operating (income) expense, net | 2 | 39 | (2) | ||||||||
| Operating income | 6,136 | 3,654 | 2,174 | ||||||||
| Interest income | 139 | 146 | 107 | ||||||||
| Interest expense | (74) | (124) | (118) | ||||||||
| Other non-operating income (expense), net | (140) | (45) | (11) | ||||||||
| 6,061 | 3,631 | 2,152 | |||||||||
| Income tax (provision) benefit | (829) | (429) | (283) | ||||||||
| Equity in net income (loss) of equity method investees | 8 | (1) | 1 | ||||||||
| Net income | $ | 5,240 | $ | 3,201 | $ | 1,870 | |||||
| Earnings per share | |||||||||||
| Basic | $ | 4.66 | $ | 2.86 | $ | 1.68 | |||||
| Diluted | 4.60 | 2.83 | 1.67 | ||||||||
| Number of shares used in per share calculations | |||||||||||
| Basic | 1,125 | 1,120 | 1,111 | ||||||||
| Diluted | 1,138 | 1,131 | 1,122 | ||||||||
| As of | November 27, 2025 | August 28, 2025 | ||||||
| Assets | ||||||||
| Cash and equivalents | $ | 9,731 | $ | 9,642 | ||||
| Short-term investments | 587 | 665 | ||||||
| Receivables | 10,184 | 9,265 | ||||||
| Inventories | 8,205 | 8,355 | ||||||
| Other current assets | 958 | 914 | ||||||
| Total current assets | 29,665 | 28,841 | ||||||
| Long-term marketable investments | 1,697 | 1,629 | ||||||
| Property, plant, and equipment | 48,477 | 46,590 | ||||||
| Operating lease right-of-use assets | 700 | 736 | ||||||
| Intangible assets | 465 | 453 | ||||||
| Deferred tax assets | 641 | 616 | ||||||
| Goodwill | 1,150 | 1,150 | ||||||
| Other noncurrent assets | 3,176 | 2,783 | ||||||
| Total assets | $ | 85,971 | $ | 82,798 | ||||
| Liabilities and equity | ||||||||
| Accounts payable and accrued expenses | $ | 9,796 | $ | 9,649 | ||||
| Current debt | 569 | 560 | ||||||
| Other current liabilities | 1,695 | 1,245 | ||||||
| Total current liabilities | 12,060 | 11,454 | ||||||
| Long-term debt | 11,187 | 14,017 | ||||||
| Noncurrent operating lease liabilities | 669 | 701 | ||||||
| Noncurrent unearned government incentives | 1,148 | 1,018 | ||||||
| Other noncurrent liabilities | 2,101 | 1,443 | ||||||
| Total liabilities | 27,165 | 28,633 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders’ equity | ||||||||
| Common stock | 127 | 127 | ||||||
| Additional capital | 13,610 | 13,339 | ||||||
| Retained earnings | 53,344 | 48,583 | ||||||
| Treasury stock | (8,152) | (7,852) | ||||||
| Accumulated other comprehensive income (loss) | (123) | (32) | ||||||
| Total equity | 58,806 | 54,165 | ||||||
| Total liabilities and equity | $ | 85,971 | $ | 82,798 | ||||
| Three months ended | November 27, 2025 | November 28, 2024 | ||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | 5,240 | $ | 1,870 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation expense and amortization of intangible assets | 2,212 | 2,030 | ||||||
Stock-based compensation | 290 | 220 | ||||||
Change in operating assets and liabilities: | ||||||||
| Receivables | (871) | (817) | ||||||
| Inventories | 150 | 170 | ||||||
| Accounts payable and accrued expenses | 156 | (241) | ||||||
Other current liabilities | 449 | (161) | ||||||
| Other noncurrent liabilities | 547 | 132 | ||||||
| Other | 238 | 41 | ||||||
| Net cash provided by operating activities | 8,411 | 3,244 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (5,389) | (3,206) | ||||||
| Purchases of available-for-sale securities | (255) | (377) | ||||||
| Proceeds from government incentives | 878 | 65 | ||||||
Proceeds from maturities and sales of available-for-sale securities | 268 | 428 | ||||||
| Other | (96) | (58) | ||||||
| Net cash used for investing activities | (4,594) | (3,148) | ||||||
| Cash flows from financing activities | ||||||||
| Repayments of debt | (2,943) | (84) | ||||||
Repurchases of common stock - withholdings on employee equity awards | (367) | (207) | ||||||
Repurchases of common stock - repurchase program | (300) | — | ||||||
| Payments of dividends to shareholders | (134) | (131) | ||||||
| Other | (1) | — | ||||||
Net cash used for financing activities | (3,745) | (422) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | 14 | (29) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 86 | (355) | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 9,646 | 7,052 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 9,732 | $ | 6,697 | ||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 27, 2025 | August 28, 2025 | November 28, 2024 | |||||||||
| GAAP gross margin | $ | 7,646 | $ | 5,054 | $ | 3,348 | |||||
| Stock-based compensation | 107 | 115 | 90 | ||||||||
| Other | — | — | 3 | ||||||||
| Non-GAAP gross margin | $ | 7,753 | $ | 5,169 | $ | 3,441 | |||||
| GAAP operating expenses | $ | 1,510 | $ | 1,400 | $ | 1,174 | |||||
| Stock-based compensation | (173) | (147) | (127) | ||||||||
| Restructure and asset impairments | — | (38) | — | ||||||||
| Other | (3) | (1) | — | ||||||||
| Non-GAAP operating expenses | $ | 1,334 | $ | 1,214 | $ | 1,047 | |||||
| GAAP operating income | $ | 6,136 | $ | 3,654 | $ | 2,174 | |||||
| Stock-based compensation | 280 | 262 | 217 | ||||||||
| Restructure and asset impairments | — | 38 | — | ||||||||
| Other | 3 | 1 | 3 | ||||||||
| Non-GAAP operating income | $ | 6,419 | $ | 3,955 | $ | 2,394 | |||||
GAAP net income | $ | 5,240 | $ | 3,201 | $ | 1,870 | |||||
| Stock-based compensation | 280 | 262 | 217 | ||||||||
| Restructure and asset impairments | — | 38 | — | ||||||||
| Loss on debt prepayments | 130 | 9 | — | ||||||||
| Other | (20) | 1 | — | ||||||||
Estimated tax effects of above and other tax adjustments | (148) | (42) | (50) | ||||||||
| Non-GAAP net income | $ | 5,482 | $ | 3,469 | $ | 2,037 | |||||
GAAP weighted-average common shares outstanding - Diluted | 1,138 | 1,131 | 1,122 | ||||||||
Adjustment for stock-based compensation | 10 | 14 | 16 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted | 1,148 | 1,145 | 1,138 | ||||||||
GAAP diluted earnings per share | $ | 4.60 | $ | 2.83 | $ | 1.67 | |||||
Effects of the above adjustments | 0.18 | 0.20 | 0.12 | ||||||||
Non-GAAP diluted earnings per share | $ | 4.78 | $ | 3.03 | $ | 1.79 | |||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| November 27, 2025 | August 28, 2025 | November 28, 2024 | |||||||||
GAAP net cash provided by operating activities | $ | 8,411 | $ | 5,730 | $ | 3,244 | |||||
Expenditures for property, plant, and equipment | (5,389) | (5,658) | (3,206) | ||||||||
| Proceeds from sales of property, plant, and equipment | 6 | 20 | 9 | ||||||||
Proceeds from government incentives | 878 | 711 | 65 | ||||||||
| Investments in capital expenditures, net | (4,505) | (4,927) | (3,132) | ||||||||
Adjusted free cash flow | $ | 3,906 | $ | 803 | $ | 112 | |||||
| FQ2-26 | GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue | $18.70 billion ± $400 million | — | $18.70 billion ± $400 million | ||||||||||||||||||||
Gross margin | 67.0% ± 1.0% | 1.0% | A | 68.0% ± 1.0% | |||||||||||||||||||
Operating expenses | $1.56 billion ± $20 million | $180 million | B | $1.38 billion ± $20 million | |||||||||||||||||||
Diluted earnings per share(1) | $8.19 ± $0.20 | $0.23 | A, B, C | $8.42 ± $0.20 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | $ | 125 | ||||||||||||||||||||
B | Stock-based compensation – research and development | 119 | |||||||||||||||||||||
B | Stock-based compensation – sales, general, and administrative | 61 | |||||||||||||||||||||
C | Tax effects of the above items and other tax adjustments | (48) | |||||||||||||||||||||
| $ | 257 | ||||||||||||||||||||||